-
1
-
-
57849138262
-
Factors influencing survival after relapse from acute lymphoblastic leukemia: A Children's Oncology Group study
-
Nguyen K, Devidas M, Cheng SC, et al. Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study. Leukemia. 2008; 22(12): 2142-2150.
-
(2008)
Leukemia
, vol.22
, Issue.12
, pp. 2142-2150
-
-
Nguyen, K.1
Devidas, M.2
Cheng, S.C.3
-
2
-
-
33846892770
-
Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: A combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)
-
DOI 10.1182/blood-2006-01-024729
-
Schultz KR, Pullen DJ, Sather HN, et al. Riskand response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG). Blood. 2007; 109(3): 926-935. (Pubitemid 46220635)
-
(2007)
Blood
, vol.109
, Issue.3
, pp. 926-935
-
-
Schultz, K.R.1
Pullen, D.J.2
Sather, H.N.3
Shuster, J.J.4
Devidas, M.5
Borowitz, M.J.6
Carroll, A.J.7
Heerema, N.A.8
Rubnitz, J.E.9
Loh, M.L.10
Raetz, E.A.11
Winick, N.J.12
Hunger, S.P.13
Carroll, W.L.14
Gaynon, P.S.15
Camitta, B.M.16
-
3
-
-
47049093795
-
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: A Children's Oncology Group study
-
Borowitz MJ, Devidas M, Hunger SP, et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study. Blood. 2008; 111(12): 5477-5485.
-
(2008)
Blood
, vol.111
, Issue.12
, pp. 5477-5485
-
-
Borowitz, M.J.1
Devidas, M.2
Hunger, S.P.3
-
4
-
-
70449711127
-
Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: A Children's Oncology Group study
-
Schultz KR, Bowman WP, Aledo A, et al. Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a Children's Oncology Group study. J Clin Oncol. 2009; 27(31): 5175-5181.
-
(2009)
J Clin Oncol
, vol.27
, Issue.31
, pp. 5175-5181
-
-
Schultz, K.R.1
Bowman, W.P.2
Aledo, A.3
-
5
-
-
70350680415
-
Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia
-
Mullighan CG, Collins-Underwood JR, Phillips LA, et al. Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia. Nat Genet. 2009; 41(11): 1243-1246.
-
(2009)
Nat Genet
, vol.41
, Issue.11
, pp. 1243-1246
-
-
Mullighan, C.G.1
Collins-Underwood, J.R.2
Phillips, L.A.3
-
6
-
-
43049139905
-
BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros
-
DOI 10.1038/nature06866, PII NATURE06866
-
Mullighan CG, Miller CB, Radtke I, et al. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature. 2008; 453(7191): 110-114. (Pubitemid 351630327)
-
(2008)
Nature
, vol.453
, Issue.7191
, pp. 110-114
-
-
Mullighan, C.G.1
Miller, C.B.2
Radtke, I.3
Phillips, L.A.4
Dalton, J.5
Ma, J.6
White, D.7
Hughes, T.P.8
Le Beau, M.M.9
Pui, C.-H.10
Relling, M.V.11
Shurtleff, S.A.12
Downing, J.R.13
-
7
-
-
58749109707
-
Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia
-
Mullighan CG, Su X, Zhang J, et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med. 2009; 360(5): 470-480.
-
(2009)
N Engl J Med
, vol.360
, Issue.5
, pp. 470-480
-
-
Mullighan, C.G.1
Su, X.2
Zhang, J.3
-
8
-
-
67249146555
-
JAK mutations in high-risk childhood acute lymphoblastic leukemia
-
Mullighan CG, Zhang J, Harvey RC, et al. JAK mutations in high-risk childhood acute lymphoblastic leukemia. Proc Natl Acad Sci U S A. 2009; 106(23): 9414-9418.
-
(2009)
Proc Natl Acad Sci U S A
, vol.106
, Issue.23
, pp. 9414-9418
-
-
Mullighan, C.G.1
Zhang, J.2
Harvey, R.C.3
-
9
-
-
78649742010
-
Identification of novel cluster groups in pediatric highrisk B-precursor acute lymphoblastic leukemia with gene expression profiling: Correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome
-
Harvey RC, Mullighan CG, Wang X, et al. Identification of novel cluster groups in pediatric highrisk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome. Blood. 2010; 116(23): 4874-4884.
-
(2010)
Blood
, vol.116
, Issue.23
, pp. 4874-4884
-
-
Harvey, R.C.1
Mullighan, C.G.2
Wang, X.3
-
10
-
-
77954516863
-
Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia
-
Harvey RC, Mullighan CG, Chen IM, et al. Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia. Blood. 2010; 115(26): 5312-5321.
-
(2010)
Blood
, vol.115
, Issue.26
, pp. 5312-5321
-
-
Harvey, R.C.1
Mullighan, C.G.2
Chen, I.M.3
-
11
-
-
77949879862
-
Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia
-
Kang H, Chen IM, Wilson CS, et al. Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia. Blood. 2010; 115(7): 1394-1405.
-
(2010)
Blood
, vol.115
, Issue.7
, pp. 1394-1405
-
-
Kang, H.1
Chen, I.M.2
Wilson, C.S.3
-
12
-
-
80052922387
-
Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: A report from the Children's Oncology Group
-
Zhang J, Mullighan CG, Harvey RC, et al. Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood. 2011; 118(11): 3080-3087.
-
(2011)
Blood
, vol.118
, Issue.11
, pp. 3080-3087
-
-
Zhang, J.1
Mullighan, C.G.2
Harvey, R.C.3
-
13
-
-
54349086521
-
Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome
-
Bercovich D, Ganmore I, Scott LM, et al. Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome. Lancet. 2008; 372(9648): 1484-1492.
-
(2008)
Lancet
, vol.372
, Issue.9648
, pp. 1484-1492
-
-
Bercovich, D.1
Ganmore, I.2
Scott, L.M.3
-
14
-
-
77649214639
-
Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: A report from the International BFM Study Group
-
Hertzberg L, Vendramini E, Ganmore I, et al. Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group. Blood. 2010; 115(5): 1006-1017.
-
(2010)
Blood
, vol.115
, Issue.5
, pp. 1006-1017
-
-
Hertzberg, L.1
Vendramini, E.2
Ganmore, I.3
-
15
-
-
70449520449
-
Myeloproliferative neoplasms: Contemporary diagnosis using histology and genetics
-
Tefferi A, Skoda R, Vardiman JW. Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics. Nat Rev Clin Oncol. 2009; 6(11): 627-637.
-
(2009)
Nat Rev Clin Oncol
, vol.6
, Issue.11
, pp. 627-637
-
-
Tefferi, A.1
Skoda, R.2
Vardiman, J.W.3
-
16
-
-
58749097408
-
Asubtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: A genomewide classification study
-
Den Boer ML, van Slegtenhorst M, De Menezes RX, et al.Asubtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genomewide classification study. Lancet Oncol. 2009; 10(2): 125-134.
-
(2009)
Lancet Oncol
, vol.10
, Issue.2
, pp. 125-134
-
-
Den Boer, M.L.1
Van Slegtenhorst, M.2
De Menezes, R.X.3
-
17
-
-
79961191931
-
Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: Results of Children's Oncology Group trial P9906
-
Bowman WP, Larsen EL, Devidas M, et al. Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: results of Children's Oncology Group trial P9906. Pediatr Blood Cancer. 2011; 57(4): 569-577.
-
(2011)
Pediatr Blood Cancer
, vol.57
, Issue.4
, pp. 569-577
-
-
Bowman, W.P.1
Larsen, E.L.2
Devidas, M.3
-
18
-
-
0037076272
-
Diagnosis of multiple cancer types by shrunken centroids of gene expression
-
DOI 10.1073/pnas.082099299
-
Tibshirani R, Hastie T, Narasimhan B, Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci U S A. 2002; 99(10): 6567-6572. (Pubitemid 34526173)
-
(2002)
Proceedings of the National Academy of Sciences of the United States of America
, vol.99
, Issue.10
, pp. 6567-6572
-
-
Tibshirani, R.1
Hastie, T.2
Narasimhan, B.3
Chu, G.4
-
19
-
-
84865118132
-
Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia
-
Roberts KG, Morin RD, Zhang J, et al. Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia. Cancer Cell. 2012; 22(2): 153-166.
-
(2012)
Cancer Cell.
, vol.22
, Issue.2
, pp. 153-166
-
-
Roberts, K.G.1
Morin, R.D.2
Zhang, J.3
-
20
-
-
34548084253
-
SNPdetector: A software tool for sensitive and accurate SNP detection
-
Zhang J, Wheeler DA, Yakub I, et al. SNPdetector: a software tool for sensitive and accurate SNP detection. PLoS Comput Biol. 2005; 1(5): e53.
-
(2005)
PLoS Comput Biol
, vol.1
, Issue.5
-
-
Zhang, J.1
Wheeler, D.A.2
Yakub, I.3
|